Tag: Immunology Excellence Award

Bulti Kumera | Immunology and Microbiology | Best Academic Researcher Award

Published on by WSA Awards

Mr. Bulti Kumera | Immunology and Microbiology | Best Academic Researcher Award

Injibara University | Ethiopia

Bulti Kumera Fufa is an Assistant Professor of Microbiology at Injibara University, Ethiopia, with more than a decade of academic and research experience in microbiology and food safety. He holds an MSc in Microbiology from Hawassa University and a BSc in Biology from Debre Berhan University. His research expertise spans food and water microbiology, antimicrobial resistance, mycotoxins, bioremediation, mushroom cultivation, and biofertilizers. He has authored and co-authored nine peer-reviewed journal articles, including publications in Microbiology Open, Discover Applied Sciences, Journal of Water and Health, and BioMed Research International, and currently has additional work under review. Dr. Fufa has served as a principal investigator on applied research projects addressing agricultural waste utilization and antimicrobial properties of natural products. His work contributes directly to public health improvement, food safety assurance, environmental sustainability, and community awareness in Ethiopia through interdisciplinary collaboration and evidence-based research.

Citation Metrics (Scopus)

2015

10
5
0

Citations
16
h-index
2
Documents
7

Citations

h-index

Documents

Scopus Profile
ORCID iD

 

Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Published on by WSA Awards

Dr. Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Department of Bacterial Diseases of Animals, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

Dr. Alireza Dehnad is an accomplished microbiologist and biotechnology researcher whose career spans over twenty-five years of impactful scientific work in veterinary microbiology, microbial biotechnology, and infectious disease research. With 88 Scopus-indexed publications, 2,503 citations, and an h-index of 27, he has demonstrated a consistent record of scholarly excellence, research productivity, and international recognition. His work encompasses diverse domains including microbial bioprocessing, secondary metabolite discovery, nanobiotechnology, antibiotic-producing Actinomycetes, viral and bacterial disease epidemiology, probiotics, wound healing applications, biopolymers for drug delivery, and microbial bioremediation. A major strength of Dr. Dehnad’s scientific career is his ability to bridge fundamental microbiology with translational biotechnology, generating research outputs that extend from laboratory innovation to real-world applications in human health, veterinary medicine, agriculture, and industrial biotechnology. He has contributed to notable advances in green nanoparticle synthesis, microbial metabolite-based therapeutics, pathogen surveillance, and probiotic industrialization. His experience supervising over 100 postgraduate theses and lecturing internationally reflects strong academic leadership, mentorship capacity, and global collaboration. Dr. Dehnad has earned prestigious national awards in recognition of his research contributions, including honors from the Razi Vaccine and Serum Research Institute and the Agricultural Biotechnology Research Institute. His leadership roles across scientific institutions, advisory committees, and biotechnology laboratories demonstrate institutional influence and commitment to advancing regional and national scientific infrastructure. While his research output is internationally visible and diverse, areas for continued development include expanding multi-center global collaborations, strengthening cross-disciplinary publications in high-impact journals, and increasing patent commercialization and industrial partnerships to further translate research outcomes into market-ready solutions.

Profiles: Scopus | ORCID

Featured Publications

Mahmoudi, F., Baradaran, B., Dehnad, A., Shanehbandi, D., Mohamed Khosroshahi, L., & Aghapour, M. (2016). The immunomodulatory activity of secondary metabolites isolated from Streptomyces calvus on human peripheral blood mononuclear cells. British Journal of Biomedical Science.

Khandan Nasab, N., Dehnad, A. R., Salimizand, H., Taherzadeh, D., Prakash, D., Verma, K. D., & Darroudi, M. (2016). Zinc selenide nanoparticles (ZnSe-NPs): Green synthesis and investigation of their cytotoxicity effects. Ceramics International.

Dehnad, A., Hamedi, J., Derakhshan-Khadivi, F., & Abusov, R. (2015). Green synthesis of gold nanoparticles by a metal resistant Arthrobacter nitroguajacolicus isolated from gold mine. IEEE Transactions on Nanobioscience.

Sadighbayan, K., Dehnad, A., Monadi, A., Mobaiyen, H., & Sadighbayan, D. (2013). An evaluation about the role of microorganisms isolated from the soil in the biological removal of toxic petroleum pollutants. Journal of Environmental Studies.

Sadigh-Eteghad, S., Dehnad, A., Mahmodi, J., Hoseyni, H., Khalili, I., & Razmaray II, N. (2013). Healing potential of a Streptomyces sp. secondary metabolite, SEM-1-111, on experimental full-thickness excision cutaneous wounds in Wistar rats. Clinical and Experimental Dermatology.

Yi Tian | Immunology and Microbiology | Best Researcher Award

Published on by WSA Awards

Yi Tian | Immunology and Microbiology | Best Researcher Award

Cangzhou Medical College | China

Hundasa Chala Nagari is a committed researcher and academic whose career reflects dedication to advancing science and contributing to education and innovation. He completed his undergraduate and postgraduate studies with distinction, building a strong foundation in science and engineering, and pursued advanced research training that shaped his expertise in sustainable development, environmental impact, and technological applications. Professionally, he has worked in teaching and research roles, mentoring students, engaging in collaborative projects, and contributing to institutional growth through active participation in academic and community initiatives. His research interests focus on energy efficiency, climate impact, materials behavior, and the application of interdisciplinary approaches that connect theory with practical solutions to societal challenges. He has conducted projects that address pressing global issues, including renewable energy systems and sustainable resource management, producing publications in peer-reviewed journals and presenting findings at international conferences. His research skills include experimental design, computational modeling, data analysis, and scientific writing, complemented by strong communication, teamwork, and leadership abilities that enable him to guide students and collaborate effectively with colleagues. In addition to technical expertise, he has demonstrated initiative in expanding research networks and enhancing academic visibility through cross-border collaborations. His contributions have been recognized with academic awards, research fellowships, and honors that highlight both his achievements and his potential to lead future scientific innovation. In conclusion, Hundasa Chala Nagari stands out as a promising academic whose education, professional experience, research interests, skills, and honors reflect his capability to contribute meaningfully to global research, and his vision of expanding high-impact publications, international collaborations, and leadership roles makes him a deserving candidate for recognition in research and innovation.

Profile: Scopus

Featured Publication

  1. The role of the Wiskott–Aldrich syndrome protein family in cancer development, invasion, and metastasis

 

Mostafa El-Amir | Immunology and Microbiology | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Mostafa El-Amir | Immunology and Microbiology | Best Researcher Award

South Valley University Qena Egypt | Egypt

Assist. Prof. Dr. Mostafa El-Amir is a distinguished academic and researcher in microbiology and immunology at Qena Faculty of Medicine, South Valley University, Egypt. His career combines extensive medical training, advanced laboratory research, and international collaboration. He has developed expertise in microbiology, immunogenetics, molecular biology, and infection control, with significant contributions to understanding autoimmune diseases and microbial resistance. His work emphasizes translational research, bridging laboratory findings with clinical applications to address challenges such as neonatal sepsis, type 1 diabetes, and parasitic infections. Beyond research, Assist. Prof. Dr. Mostafa El-Amir has demonstrated strong leadership through his role as Manager of the Infection Prevention and Control Unit at South Valley University Hospitals, implementing strategies to reduce hospital-acquired infections and promote patient safety. He is also a committed educator, mentoring students and guiding young researchers in microbiology and immunology. With publications in internationally indexed journals and active participation in academic networks, Assist. Prof. Dr. Mostafa El-Amir has established himself as a respected researcher whose contributions extend from local healthcare improvements to international scientific collaborations. His dedication to advancing both medical science and community health reflects his dual commitment to academic excellence and societal impact.

Professional Profile

Scopus

Education

Assist. Prof. Dr. Mostafa El-Amir educational background reflects a steady advancement from general medical training to specialization in microbiology and immunology. He completed his undergraduate degree in Medicine and Surgery at South Valley University, followed by a master’s degree in microbiology and immunology at Assiut University. His master’s research focused on nosocomial infections, laying the foundation for his later interest in hospital infection control. Driven by a passion for advanced research, he pursued doctoral studies in microbiology and immunology at South Valley University. His doctoral thesis investigated genetic factors in autoimmune responses, particularly the role of type 1 diabetes-associated genes. During his studies, he joined the Immunogenetic Laboratory at Turku University in Finland, where he gained international research exposure and advanced technical training in molecular biology and immunogenetics. His academic path also included specialized training in leadership and teaching development, preparing him to serve both as a researcher and an educator. This blend of national and international training has shaped Dr. El-Amir into a well-rounded academic who integrates medical practice, laboratory research, and innovative teaching, making him a recognized scholar in his field.

Professional Experience

Assist. Prof. Dr. Mostafa El-Amir professional journey reflects a strong balance of medical service, academic teaching, and institutional leadership. He began his career as a House Officer at Sohag University Hospitals, gaining practical experience in internal medicine, pediatrics, surgery, ENT, obstetrics, and emergency care. Following this, he served as a Resident in Internal Medicine before moving into academia as a Demonstrator of Microbiology and Immunology at South Valley University. His teaching roles expanded as he became Assistant Lecturer, Lecturer, and later Assistant Professor of Microbiology and Immunology at Qena Faculty of Medicine. Alongside his teaching and research duties, Dr. El-Amir has played important administrative roles, most notably as the Manager of the Infection Prevention and Control Unit at South Valley University Hospitals, where he developed infection control protocols and oversaw their implementation. His international experience includes several research missions and a postdoctoral fellowship at Turku University in Finland, where he specialized in immunogenetics and molecular biology techniques. These experiences have enriched his career by combining local healthcare leadership with global scientific exposure. Today, he continues to integrate teaching, research, and community service, contributing significantly to medical education and healthcare improvement in Egypt.

Research Interests

Assist. Prof. Dr. Mostafa El-Amir research interests span microbiology, immunology, molecular genetics, and infection control. He has a particular focus on the genetic and immunological mechanisms of type 1 diabetes, exploring how HLA polymorphisms and other genetic factors influence disease susceptibility and autoimmune responses. His collaboration with the Finnish Pediatric Diabetes Register enabled him to contribute to groundbreaking studies on genetic predisposition to autoimmune diseases in different populations. He also has a strong interest in rapid diagnostic techniques for infectious diseases, having investigated PCR-based detection methods for neonatal sepsis and other microbial infections. Another significant area of his research lies in antimicrobial resistance and nosocomial infections, where he has studied resistant strains and developed strategies for hospital infection control. Additionally, he has explored the immunological impact of vitamin D receptor polymorphisms, the immunomodulatory potential of mesenchymal stem cells, and the genetic diversity of parasites such as Schistosoma haematobium. His research integrates molecular biology with applied clinical solutions, emphasizing translational outcomes that can improve diagnostics, treatment, and preventive strategies. Through this multidisciplinary approach, Assist. Prof. Dr. Mostafa El-Amir addresses both fundamental questions in immunology and urgent health concerns affecting communities worldwide.

Research Skills

Assist. Prof. Dr. Mostafa El-Amir is equipped with a comprehensive set of research and laboratory skills that enable him to conduct advanced investigations in microbiology and immunology. His foundational expertise includes microbial culture, biochemical testing, and antibiotic sensitivity analysis, which provide essential diagnostic and teaching skills. Building on this foundation, he has acquired advanced molecular biology capabilities such as plasmid profiling, ELISA assays, HLA typing, PCR optimization, and real-time PCR for analyzing single nucleotide polymorphisms. These techniques have been applied extensively in his studies on type 1 diabetes, autoimmune diseases, and infectious disease diagnostics. He has also gained experience in applying bioinformatics tools for literature review, data analysis, and molecular epidemiology, supporting the design and interpretation of complex studies. In addition, he has leadership experience in infection prevention and control, having managed institutional programs to reduce nosocomial infections. His skills extend beyond the laboratory to include computer proficiency with ICDL certification and fluency in English, which enables him to collaborate internationally and publish in leading journals. The combination of classical microbiological techniques, advanced genetic methodologies, and institutional leadership demonstrates his versatility and strength as a medical researcher and educator.

Awards and Honors

Throughout his career, Assist. Prof. Dr. Mostafa El-Amir has been recognized for his academic achievements, leadership roles, and contributions to research. His international recognition includes scientific missions and a postdoctoral fellowship at Turku University in Finland, where he contributed to immunogenetic studies and enhanced his expertise in molecular biology. These fellowships reflect international trust in his research capacity and mark significant milestones in his career development. Within South Valley University, he has been honored with appointments to key roles, including his promotion to Assistant Professor of Microbiology and Immunology and his leadership as Manager of the Infection Prevention and Control Unit. These responsibilities acknowledge his ability to lead both academically and institutionally. His research has also earned recognition through publication in respected journals indexed in Scopus, PubMed, and Web of Science, affirming the international reach of his work. Furthermore, his commitment to medical education has been recognized through his involvement in faculty development and teaching training programs. While his contributions are already widely acknowledged, his career trajectory positions him for further international honors, awards, and leadership recognition in the field of microbiology and immunology.

Publication Top Notes

  • Diagnosis of onychomycosis clinically by nail dermoscopy versus microbiological diagnosis — 2020

  • Rapid diagnosis of neonatal sepsis by PCR for detection of 16S rRNA gene, while blood culture and PCR results were similar in E. coli-predominant EOS cases — 2019

  • HLA-B08 Carry a Risk for Type 1 Diabetes among Cow’s Milk Exposed Egyptian Infants and Unmarked Linkage Disequilibrium with DR3-DQA105-DQB1*02 Haplotype — 2019

  • Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy — 2019

  • Immunomodulatory effect of mesenchymal stem cells: Cell origin and cell quality variations — 2019

  • The association of the HLA-A24:02, B39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA-DR/DQ haplotypes in Finns — 2017

Conclusion

Assist. Prof. Dr. Mostafa El-Amir stands out as a highly accomplished researcher, educator, and leader in microbiology and immunology. His career reflects a unique combination of advanced scientific research, practical healthcare leadership, and dedicated teaching. His studies on type 1 diabetes genetics, autoimmune responses, microbial resistance, and parasitic infections contribute significantly to both scientific knowledge and public health solutions. With international training in Finland and collaborative research spanning Europe and Egypt, he has demonstrated his capacity to operate in global research environments while addressing pressing local health issues. His leadership in infection control at South Valley University Hospitals directly improved healthcare quality, while his mentorship of students continues to shape the next generation of medical professionals. Dr. El-Amir’s research is widely recognized through publications in high-impact journals, enhancing his academic profile and visibility. Looking forward, he is well-positioned to expand his international collaborations, increase his contributions to top-tier journals, and assume broader leadership roles in scientific networks. His outstanding academic contributions, leadership, and potential for future innovation make him a deserving candidate for international recognition and awards in the medical sciences.

Aghil Sharifzadeh | Immunology and Microbiology | Best Research Article Award

Published on by WSA Awards

Dr. Aghil Sharifzadeh | Immunology and Microbiology | Best Research Article Award

Associate Professor, Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Iran.

Dr. Aghil Sharifzadeh is an Associate Professor in the Department of Microbiology and Immunology at the Faculty of Veterinary Medicine, University of Tehran. His research primarily focuses on medical mycology, with a particular interest in dermatophytes and Candida species. Dr. Sharifzadeh has contributed significantly to understanding the antifungal susceptibility patterns and virulence factors of various fungal pathogens. His work includes studies on the antifungal susceptibility and enzymatic activities of dermatophyte species isolated from clinical specimens in Iran, as well as evaluations of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel genital tract. Through his research, Dr. Sharifzadeh aims to enhance the diagnosis and treatment of fungal infections in both humans and animals. His dedication to the field is evident in his numerous publications and ongoing research projects, which continue to contribute to the advancement of medical mycology.

Professional Profile

Education

Dr. Aghil Sharifzadeh has pursued advanced studies in veterinary medicine and microbiology, culminating in his current role as an Associate Professor at the University of Tehran. His academic journey has equipped him with a robust foundation in medical mycology, enabling him to conduct in-depth research on fungal pathogens affecting both humans and animals. Through his education, Dr. Sharifzadeh has developed expertise in various microbiological techniques and methodologies, which he applies in his research to investigate the characteristics and behaviors of different fungal species. His educational background has been instrumental in shaping his research interests and guiding his contributions to the field of medical mycology.

Professional Experience

Dr. Aghil Sharifzadeh serves as an Associate Professor in the Department of Microbiology and Immunology at the Faculty of Veterinary Medicine, University of Tehran. In this role, he engages in teaching, research, and mentorship, contributing to the academic development of students and the advancement of scientific knowledge in medical mycology. His professional experience includes conducting research on the antifungal susceptibility and virulence factors of various fungal pathogens, with a focus on dermatophytes and Candida species. Dr. Sharifzadeh’s work extends to studying fungal infections in animals, such as green iguanas, highlighting his commitment to understanding and addressing fungal diseases across different species. His expertise and contributions have established him as a respected figure in the field of medical mycology.

Research Interests

Dr. Aghil Sharifzadeh’s research interests lie in the field of medical mycology, with a particular focus on the antifungal susceptibility and virulence factors of dermatophytes and Candida species. He investigates the enzymatic activities of these fungal pathogens, such as keratinase, elastase, lipase, and DNase, to understand their roles in infection and pathogenicity. Dr. Sharifzadeh also explores the presence and impact of fungal agents in various animal species, including studies on mixed infections in green iguanas. His research aims to enhance the diagnosis, treatment, and prevention of fungal infections in both human and veterinary medicine. Through his work, Dr. Sharifzadeh contributes to the broader understanding of fungal diseases and their management.

Research Skills

Dr. Aghil Sharifzadeh possesses a comprehensive set of research skills in medical mycology. He is proficient in conducting antifungal susceptibility testing and analyzing the enzymatic activities of fungal pathogens. His expertise includes isolating and identifying various fungal species from clinical specimens, as well as evaluating their virulence factors. Dr. Sharifzadeh is skilled in designing and implementing research studies that investigate the characteristics and behaviors of dermatophytes and Candida species. His methodological approach combines laboratory techniques with clinical insights, enabling him to produce research that is both scientifically rigorous and clinically relevant. These skills have been instrumental in advancing knowledge in the field of medical mycology.

Awards and Honors

Dr. Aghil Sharifzadeh’s contributions to medical mycology have been recognized through various awards and honors. His research has garnered citations and acknowledgment within the scientific community, reflecting the impact and significance of his work. Dr. Sharifzadeh’s dedication to advancing the understanding of fungal pathogens and improving treatment strategies has earned him a respected position among his peers. His achievements underscore his commitment to excellence in research and his role in shaping the field of medical mycology.

Conclusion

Dr. Aghil Sharifzadeh stands as a prominent figure in the field of medical mycology, with a career dedicated to exploring the complexities of fungal pathogens and their impact on health. His extensive research on the antifungal susceptibility and virulence factors of dermatophytes and Candida species has contributed significantly to the scientific community’s understanding of these organisms. Through his role as an Associate Professor at the University of Tehran, Dr. Sharifzadeh continues to educate and mentor the next generation of scientists, fostering a culture of inquiry and innovation. His work not only advances scientific knowledge but also has practical implications for the diagnosis and treatment of fungal infections in both humans and animals. Dr. Sharifzadeh’s ongoing commitment to research excellence ensures his continued influence in the field of medical mycology.

Publications Top Notes

  1. Title: Raisin Production by Convective–Microwave Dryer and Optimization of Ochratoxin A Content, Physicochemical, Sensory Characteristics, and Fungal Load of Raisin
    Authors: Majid Behfar, Ali Heshmati, Aghil Sharifzadeh, Maryam Taghdir, Sepideh Abbaszadeh
    Journal: Food Science and Nutrition
    Year: 2025

  2. Title: Impact of oleuropein on Candida albicans and Staphylococcus aureus adhesion and its mediated toxicity in Zebrafish (Danio rerio) embryos
    Authors: Samira Karzani, Aghil Sharifzadeh, Bahar Nayeri-Fasaei, Aram Sharifi, Ali Pourshaban Shahrestani
    Journal: Iranian Journal of Microbiology
    Year: 2025

  3. Title: Evaluation of antifungal and apoptotic effects of linalool, citral, and carvacrol separately and in combination with nystatin against clinical isolates of Pichia kudriavzevii
    Authors: Aghil Sharifzadeh, Bahar Nayeri-Fasaei, Sepideh Asadi, Mahdi Houshmandzad, Mohammad Hosein Ghaffari
    Journal: BMC Microbiology
    Year: 2024
    Citations: 2

  4. Title: Antimicrobial and anti-biofilm properties of oleuropein against Escherichia coli and fluconazole-resistant isolates of Candida albicans and Candida glabrata
    Authors: Mohammad Ali Esfandiary, Ali Reza Khosravi, Sepideh Asadi, Jalal Hassan, Aghil Sharifzadeh
    Journal: BMC Microbiology
    Year: 2024
    Citations: 2

  5. Title: A Report of Aflatoxicosis in Hand-fed Ewe Lambs Exhibiting Icterus After Hepatic Failure and Hemoglobinuria
    Authors: Hossein Aminianfar, Nazanin Samiee, Aghil Sharifzadeh, Seyedeh Fatemeh Safavi, Moahammadreza Mokhtari Hooyeh
    Journal: Iranian Journal of Veterinary Medicine
    Year: 2024

 

Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Published on by WSA Awards

Dr. Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Dr. Jean Michel Bolla is a distinguished researcher specializing in microbiology, biochemistry, and antibiotic resistance. With over 30 years of experience, he has made significant contributions to understanding bacterial resistance mechanisms, particularly efflux-mediated resistance in Gram-negative bacteria. As the Director of Research at Inserm U-1261, he has led pioneering studies in bacterial physiology and virulence, as well as the development of screening platforms for antibiotic-resistant bacteria. His leadership in the Bac-Screen platform, which enables high-throughput screening of antimicrobial compounds, highlights his commitment to innovative research. Dr. Bolla has supervised multiple PhD students and postdoctoral researchers, securing major research funding from national and international agencies. His work has been recognized through invited talks at international conferences and a patent related to diagnostic tools for antibiotic resistance. Additionally, he has contributed significantly to academia through teaching roles at Aix-Marseille Université and Université de Corse. His research continues to shape the field of antimicrobial resistance, addressing one of the most pressing global health challenges. Through his expertise, leadership, and dedication to scientific advancement, Dr. Bolla has established himself as a leading figure in microbiology and antibiotic resistance research.

Professional Profile

Education

Dr. Jean Michel Bolla holds a PhD in Biochemistry and Molecular Biology from UPR9027 CNRS, Marseille, awarded in 1990. His doctoral research focused on protein export and assembly in Escherichia coli, conducted under the supervision of Dr. JM Pagès. Following his PhD, he pursued a postdoctoral fellowship at Inserm-APHP, Paris, where he worked on iron starvation responses in Listeria monocytogenes under Dr. P. Berche. His advanced training includes specialization in Campylobacter porins at the Laboratory Centre for Disease Control in Ottawa and Winnipeg, Canada in 1997 and 1998. In 2001, he obtained his Habilitation à Diriger des Recherches (HDR) from the Faculty of Medicine, Timone, Marseille, enabling him to supervise doctoral research. His extensive academic training has provided him with a strong foundation in molecular microbiology, biochemistry, and antibiotic resistance. Through continuous education and research, Dr. Bolla has developed a deep understanding of bacterial physiology, antimicrobial resistance mechanisms, and drug discovery. His educational background has been instrumental in shaping his career as a leading researcher in microbiology and antibiotic resistance, allowing him to contribute groundbreaking insights to the field.

Professional Experience

Dr. Jean Michel Bolla has had an illustrious career in research, spanning over three decades. He began as a postdoctoral researcher at Inserm-APHP, Paris, before joining Inserm as a Chargé de Recherche in 1992. Over the years, he advanced within Inserm, holding key research positions, and became Director of Research at U-1261 in 2018. He has led major research initiatives, including the establishment of the Bac-Screen platform, a high-throughput screening system for antibiotic resistance studies. From 2007 to 2011, he also served as an Associate Professor at the Université de Corse, where he contributed significantly to teaching and student mentorship. Throughout his career, Dr. Bolla has supervised seven PhD students and three postdoctoral researchers, demonstrating his commitment to training future scientists. He has been an invited speaker at multiple international conferences, sharing his expertise in antibiotic resistance. His ability to secure major research funding, including grants from CNRS, ANR, and FEAMPA, underscores his impact in the field. His leadership roles at Inserm and collaborations with various research institutions have solidified his reputation as an expert in microbiology and antibiotic resistance.

Research Interest

Dr. Jean Michel Bolla’s research primarily focuses on antibiotic resistance mechanisms, with a particular emphasis on efflux-mediated resistance in Gram-negative bacteria. His work explores the physiology and virulence of bacterial pathogens, including Campylobacter jejuni and Listeria monocytogenes. He is deeply involved in drug discovery and screening technologies, having developed the Bac-Screen platform to identify novel antimicrobial compounds and assess their mechanisms of action. His research also extends to bacterial membrane permeability, studying how bacterial outer membrane porins influence antibiotic uptake and resistance. More recently, he has been engaged in synthetic antibacterial polymer development for therapeutic applications. His work contributes to understanding multidrug resistance mechanisms, a major global health challenge, and seeks innovative solutions to combat bacterial infections. Additionally, he collaborates on projects involving diagnostic tools for detecting antimicrobial resistance, aiming to improve early detection and treatment strategies. Through his research, Dr. Bolla strives to bridge the gap between basic microbiology and clinical applications, working towards the development of effective antimicrobial strategies to tackle the increasing threat of drug-resistant bacteria worldwide.

Research Skills

Dr. Jean Michel Bolla possesses a diverse range of research skills, with expertise in molecular microbiology, biochemistry, and antimicrobial resistance. He has extensive experience in protein purification, bacterial physiology studies, and genetic manipulation of bacterial pathogens. His work in high-throughput screening techniques has been pivotal in identifying new inhibitors for efflux pumps in Gram-negative bacteria. He is proficient in drug discovery methodologies, including antibiotic susceptibility testing, mode-of-action studies, and bacterial membrane permeability analysis. Additionally, he has expertise in structural and functional analysis of bacterial outer membrane proteins, which play a crucial role in drug resistance. Dr. Bolla is also skilled in cell culture techniques, bioinformatics, and statistical analysis for interpreting large-scale screening data. His ability to secure major research funding highlights his competence in grant writing and project management. Furthermore, his teaching and mentorship experience demonstrate his ability to train and guide students in advanced microbiology research techniques. His research skills make him a valuable asset in the fight against antimicrobial resistance, as he continues to develop innovative solutions to combat bacterial infections.

Awards and Honors

Dr. Jean Michel Bolla has been recognized for his outstanding contributions to microbiology and antibiotic resistance research. In 2007, he was awarded the Inserm-Université Interface Contract, acknowledging his excellence in research and academic collaboration. His work in antimicrobial resistance has also been recognized through significant research grants from CNRS, ANR, and FEAMPA, underscoring the impact of his studies in drug discovery and bacterial resistance mechanisms. In 2019, his Bac-Screen platform was designated an Aix-Marseille University Technological Platform, a prestigious recognition that was renewed in 2023 for its critical role in antibiotic resistance research. His contributions to the field have also led to an international patent (WO 2023/139263 A1) for a diagnostic tool to detect drug resistance. Additionally, he has been an invited speaker at leading scientific conferences, including GRS-GRC Multidrug Efflux Systems and The 3rd International Electronic Conference on Antibiotics. His expertise and dedication to advancing microbial research have positioned him as a leading scientist in his field, earning him widespread recognition and respect.

Conclusion

Dr. Jean Michel Bolla is a highly accomplished microbiologist with a strong research background in antibiotic resistance and bacterial physiology. His contributions to understanding efflux-mediated resistance in Gram-negative bacteria have had a profound impact on the field. As Director of Research at Inserm U-1261, he has demonstrated exceptional leadership, securing major research funding and spearheading innovative screening platforms for antimicrobial resistance studies. His dedication to mentoring PhD students and postdoctoral researchers underscores his commitment to advancing scientific knowledge. Through his numerous research projects, international collaborations, and conference presentations, he continues to make significant strides in addressing the global challenge of antibiotic resistance. His patent for a diagnostic tool in antimicrobial resistance showcases his ability to translate research into real-world applications. Recognized through awards and honors, Dr. Bolla is a leading expert in microbiology and antimicrobial resistance. His work has positioned him as a key figure in drug discovery and bacterial resistance research, making him a strong contender for the Best Researcher Award. His career is a testament to scientific excellence, innovation, and dedication to global health challenges.

Publications Top Notes

  1. Title: RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria
    Authors: M. Novelli, Marine; J.M. Bolla, Jean Michel
    Year: 2024
    Citations: 5

  2. Title: Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities
    Authors: A. Di Maio, Attilio; H. Olleik, Hamza; É. Courvoisier-Dezord, Élise; M. Maresca, Marc; M. Robin, Maxime
    Year: 2024
    Citations: 1

  3. Title: Antitubercular potential and pH-driven mode of action of salicylic acid derivatives
    Authors: J. Laudouze, Janïs; T. Francis, Thomas; E. Forest, Emma; P. Santucci, Pierre; J.F. Cavalier, Jean-François
    Year: 2024

  4. Title: Synthesis and antimicrobial testing of 5-fluorouracil derivatives
    Authors: M.U. Patil, Mrunal Unmesh; S. Krykun, Serhii; F. Garzino, Frédéric; J.M. Bolla, Jean Michel; M. Camplo, Michel
    Year: 2023
    Citations: 5

  5. Title: The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
    Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; M. Preusse, Matthias; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
    Year: 2022
    Citations: 11

  6. Title: An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains
    Authors: A. Troudi, Azza; J.M. Bolla, Jean Michel; N. Klibi, Naouel; J.M. Brunel, Jean Michel
    Year: 2022
    Citations: 4

  7. Title: The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane
    Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; H. Rodríguez-Villalobos, Héctor; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
    Year: 2022
    Citations: 6

  8. Title: Nanoarchitectonics of Electrically Activable Phosphonium Self-Assembled Monolayers to Efficiently Kill and Tackle Bacterial Infections on Demand
    Authors: S. Carrara, Serena; F. Rouvier, Florent; S. Auditto, Sanjana; J.M. Bolla, Jean Michel; J.M. Raimundo, Jean Manuel
    Year: 2022
    Citations: 6

 

Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Published on by WSA Awards

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

  1. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
    • Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
    • Year: 2024
    • Journal: Acta Neuropathologica
    • Volume: 148(1), Pages 2
  2. Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
    • Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
    • Year: 2024
    • Journal: Journal of Immunological Methods
    • Volume: 534, Article 113747
  3. Prion Protein: The Molecule of Many Forms and Faces
    • Authors: Kovač, V., Šerbec, V.Č.
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
    • Volume: 23(3), Article 1232
    • Citations: 21
  4. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
    • Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
    • Year: 2021
    • Journal: Journal of Allergy and Clinical Immunology
    • Volume: 148(2), Pages 621–626.e7
    • Citations: 36
  5. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
    • Authors: Kovač, V., Čurin Šerbec, V.
    • Year: 2018
    • Journal: Biomarker Insights
    • Volume: 13
    • Citations: 6
  6. Targeting malignant brain tumors with antibodies
    • Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
    • Year: 2017
    • Journal: Frontiers in Immunology
    • Volume: 8(SEP), Article 1181
    • Citations: 57
  7. Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
    • Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
    • Year: 2017
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 484(1), Pages 45–50
    • Citations: 10
  8. New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    • Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
    • Year: 2017
    • Journal: Zdravniski Vestnik
    • Volume: 86(5-6), Pages 177–184
  9. Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
    • Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
    • Year: 2016
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 481(1-2), Pages 1–6
    • Citations: 10
  10. Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
    • Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
    • Year: 2016
    • Journal: Molecules
    • Volume: 21(10), Article 1300
    • Citations: 9

 

 

Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Published on by WSA Awards

Dr. Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Hacettepe University Faculty of Medicine, Department of Pediatric Immunology and Allergy at Hacettepe University Faculty of Medicine, Turkey

Dr. Hilal Ünsal is a distinguished pediatric allergist and clinical immunologist specializing in the diagnosis and management of allergies and immunodeficiencies in children. With extensive training and clinical experience, Dr. Ünsal has become a prominent figure in the field of pediatric allergy, contributing significantly to both clinical practice and research. Currently pursuing advanced studies in Pediatric Allergy and Clinical Immunology at Hacettepe University, she combines her clinical expertise with a strong research background, particularly in primary immunodeficiencies, food allergies, and asthma. Her work has been published in several reputable journals, and she is an active participant in international conferences, reflecting her commitment to advancing medical knowledge and improving patient outcomes.

Professional Profile

Education

Dr. Ünsal earned her Medical Degree from Gazi University, Faculty of Medicine in 2012, where she graduated as an honor student. She then pursued a residency in pediatrics at Health Sciences University Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, completing her training in 2018. Currently, she is completing a Clinical Fellowship in Pediatric Allergy and Clinical Immunology at Hacettepe University, a program that is enhancing her expertise in the immunologic aspects of pediatric diseases. Dr. Ünsal’s academic path reflects her dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Ünsal’s professional journey has been centered on pediatric allergy and immunology. After completing her medical education and residency, she further honed her skills in pediatric immunology during her fellowship at Hacettepe University, one of Turkey’s leading medical institutions. Over the years, Dr. Ünsal has actively contributed to the diagnosis and management of pediatric allergies, asthma, and immunodeficiencies, working in various clinical settings. Her experience spans the diagnosis of IgE-mediated food allergies, asthma exacerbations, and immunodeficiencies, as well as advanced research in these areas. She has gained a reputation for her meticulous approach to clinical research and patient care.

Research Interests

Dr. Ünsal’s research focuses on the intricate relationships between primary immunodeficiencies, genetics, and pediatric allergies. Her specific interests include food allergies, drug allergies, allergic rhinitis, and asthma, with a strong emphasis on understanding the genetic and immunological factors contributing to these conditions in children. She is particularly dedicated to identifying novel allergens and improving diagnostic methods for food allergies, as well as exploring the role of oxidative stress in asthma. Through her research, Dr. Ünsal aims to improve the quality of life for children suffering from these conditions by enhancing early diagnosis, treatment strategies, and prevention methods.

Research Skills

Dr. Ünsal has developed robust research skills, particularly in the areas of biostatistics, immunological testing, and clinical research methodologies. She is proficient in using SPSS for data analysis, enabling her to conduct rigorous statistical evaluations of her research data. Her research skills are further enhanced by her involvement in multiple projects on food allergies, asthma, and immunodeficiencies. Dr. Ünsal’s expertise in interpreting complex immunological data, along with her ability to work with diverse patient populations, has allowed her to contribute to significant studies in her field. Her active participation in both clinical and experimental research ensures that her work remains at the forefront of pediatric allergy and immunology.

Awards and Honors

Dr. Ünsal’s academic and research excellence has been recognized by her peers and academic institutions. As an honor student at Gazi University, she demonstrated early promise in her medical career. Her ongoing contributions to the field of pediatric allergy and immunology have earned her opportunities to present at numerous prestigious conferences, including the European Academy of Allergy and Clinical Immunology (EAACI) Congress and the World Allergy Congress. Additionally, her research has been published in well-regarded journals such as Pediatric Allergy and Immunology and Turkish Journal of Medical Sciences, which highlights her commitment to advancing knowledge in her field.

Conclusion

Dr. Hilal Ünsal is highly deserving of the Best Researcher Award based on her extensive body of work, leadership in research, and active participation in international conferences. Her expertise in pediatric immunology and allergy is well-documented, and her ongoing research in immunodeficiencies and food allergies is crucial for advancing clinical practice in these areas. While further strengthening her clinical impact and broadening her research funding could enhance her profile, her current contributions to the field place her as a prominent figure in her discipline. Dr. Ünsal is well-positioned for continued excellence in research, making her an excellent candidate for this prestigious award

Publication Top Notes

  1. Title: The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs
    • Authors: İlgün Gürel, D., Ünsal, H., Soyak Aytekin, E., Ersoy Evans, S., Şekerel, B.E.
    • Year: 2024
  2. Title: A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
    • Authors: Ünsal, H., Caka, C., Bildik, H.N., Tezcan, İ., Çağdaş, D.
    • Year: 2024
    • Citations: 2
  3. Title: Cupressus arizonica: an emerging aeroallergen for East Mediterranean children
    • Authors: Ünsal, H., Şahiner, Ü.M., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
  4. Title: Phenotypes of persistent hen’s egg allergy in children and adolescents
    • Authors: Ünsal, H., Dal, S.T., Akarsu, A., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
    • Citations: 2
  5. Title: Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma
    • Authors: Soyak Aytekin, E., Sahiner, U.M., Tuten Dal, S., Sekerel, B.E., Soyer, O.
    • Year: 2022
    • Citations: 9
  6. Title: IgE mediated legume allergy in east Mediterranean children: A reflection of multiple food allergies
    • Authors: Soyak Aytekin, E., Unsal, H., Sahiner, U.M., Soyer, O., Sekerel, B.E.
    • Year: 2022
    • Citations: 4
  7. Title: Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma
    • Authors: Tunçer, F., Şahiner, Ü.M., Ocak, M., Şekerel, B.E., Birben, E.
    • Year: 2022
    • Citations: 4
  8. Title: Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
    • Authors: Sekerel, B.E., Unsal, H., Sahiner, U.M., Karakaya, G., Kalyoncu, A.F.
    • Year: 2022
    • Citations: 5
  9. Title: Food allergy management has been negatively impacted during the COVID-19 pandemic
    • Authors: Soyak Aytekin, E., Tüten Dal, S., Ünsal, H., Soyer, Ö., Şekerel, B.E.
    • Year: 2021
    • Citations: 2
  10. Title: Allergic reactions against COVID-19 vaccines
    • Authors: Ünsal, H., Şekerel, B.E., Şahiner, Ü.M.
    • Year: 2021
    • Citations: 4

 

Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Published on by WSA Awards

Dr. Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Senior Researcher of Novosibirsk state university, Russia.

Elena Prokopyeva is a distinguished researcher and educator based at the Federal Research Center of Fundamental and Translational Medicine in Novosibirsk, Russia. Her academic journey began at Novosibirsk State University and progressed through advanced research positions at institutions like the FBRI State Research Center of Virology and Biotechnology ‘Vector’. Dr. Prokopyeva holds a PhD focused on the phenotypic and genotypic properties of influenza viruses and has made significant contributions to virology, studying various viruses including influenza, coronaviruses, and adenoviruses. Her expertise extends to virological methods, immunohistochemistry, and serological diagnostics. Dr. Prokopyeva has authored numerous high-impact publications, reflecting her extensive research in infectious diseases and cell biology. She is also a reviewer for MDPI and an expert for the Russian Science Foundation. Her achievements, coupled with her teaching roles in embryology and histology, underscore her valuable contributions to the scientific community.

Profile
Education

Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013.

Professional Experience

Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community.

Research Interest

Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.

Research Skills

Elena Prokopyeva possesses a diverse and advanced skill set in research, particularly within virology and infectious diseases. Her expertise includes virological methods such as virus isolation, infection assays, and the determination of virus susceptibility to inhibitors. She is adept in immunofluorescence and immunohistochemistry techniques, essential for studying viral interactions and pathogenesis. Prokopyeva’s proficiency extends to serological diagnostics using hemagglutination and microneutralization assays, as well as molecular techniques like RNA/DNA isolation, real-time PCR, and gel electrophoresis. Her experience with light and electron microscopy further enhances her capability to analyze viral structures and disease mechanisms. Prokopyeva’s role as a reviewer and expert for scientific foundations highlights her strong analytical skills and contributions to advancing the field of virology. Her comprehensive research skills, combined with her active participation in professional organizations, underscore her significant impact and ongoing commitment to her field.

Awards and Recognition

Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award.

Conclusion

Elena Prokopyeva is a strong candidate for the Best Researcher Award due to her extensive research expertise, impressive publication record, and significant contributions to the field of virology. Her work in understanding and combating viral diseases, coupled with her role in educating future scientists, underscores her value as a researcher. Addressing the areas for improvement could further enhance her standing and impact in the scientific community. Overall, Prokopyeva’s achievements and ongoing contributions make her a worthy candidate for the award.

Publications Top Notes

  • “Genetic Diversity of the Human Adenovirus C Isolated from Hospitalized Children in Russia (2019–2022)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Dubovitskiy, N.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2024
    • Volume: 16(3)
    • Article Number: 386
    • Citations: 1
  • “Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation”
    • Authors: Mazin, M.E., Perevalova, A.M., Yarushkin, A.A., Gulyaeva, L.F., Pustylnyak, V.O.
    • Journal: Biochemistry (Moscow)
    • Year: 2023
    • Volume: 88(8)
    • Pages: 1061–1069
  • “Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Sobolev, I.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(4)
    • Article Number: 934
    • Citations: 8
  • “Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia”
    • Authors: Dubovitskiy, N., Derko, A., Sobolev, I., Shestopalov, A., Sharshov, K.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(3)
    • Article Number: 734
    • Citations: 1
  • “Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018”
    • Authors: Prokopyeva, E.A., Kurskaya, O.G., Solomatina, M.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Infection in Developing Countries
    • Year: 2023
    • Volume: 17(2)
    • Pages: 251–259
    • Citations: 2
  • “Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation”
    • Authors: Mazin, M.E., Yarushkin, A.A., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: Molecular Biology Reports
    • Year: 2022
    • Volume: 49(5)
    • Pages: 4089–4093
    • Citations: 2
  • “Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013–2020)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Anoshina, A.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Microbiology, Immunology and Infection
    • Year: 2022
    • Volume: 55(2)
    • Pages: 336–340
    • Citations: 3
  • “Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau”
    • Authors: Kurskaya, O., Prokopyeva, E., Bi, H., Wei, L., Sharshov, K.
    • Journal: Viruses
    • Year: 2022
    • Volume: 14(2)
    • Article Number: 360
    • Citations: 7
  • “Etiology of influenza-like illnesses in the population of Novosibirsk City in the 2018-2019 epidemic season”
    • Authors: Kurskaya, O.G., Anoshina, A.V., Leonova, N.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Russian Journal of Infection and Immunity
    • Year: 2021
    • Volume: 11(4)
    • Pages: 723–736
    • Citations: 2
  • “Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation”
    • Authors: Yarushkin, A.A., Mazin, M.E., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: European Journal of Pharmacology
    • Year: 2020
    • Volume: 879
    • Article Number: 173135
    • Citations: 6

 

Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Published on by WSA Awards

Assoc Prof Dr. Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Supervisor of Islamic Azad University, Iran.

Dr. Fahimeh Alizadeh is an accomplished researcher and educator in the field of microbial biotechnology, currently serving as an Associate Professor at the Department of Biology, Islamic Azad University, Gachsaran, Iran. With over two decades of experience in academia, she has previously held roles at the Yasooj Branch of Islamic Azad University, including positions as Head of the Department of Biology and Paramedical Sciences. Dr. Alizadeh’s research expertise encompasses microbial interactions, nanoparticle applications, and antifungal and antibacterial agents. Her significant contributions include research on the molecular mechanisms of Candida species, nanoparticle-based therapies, and biofilm formation. She has secured notable research grants and published extensively in high-impact journals. Dr. Alizadeh holds a Ph.D. from the University of Putra Malaysia and a Post-Doctoral fellowship from the same institution. Her extensive publication record and leadership in scientific research underscore her prominent role in her field.

Profile
Education

Fahimeh Alizadeh holds a robust academic background in microbiology and microbial biotechnology. She completed her Bachelor’s and Master’s degrees in Biology-Microbiology at Islamic Azad University, Iran, where she laid the foundation for her specialization. She further advanced her expertise by earning a Ph.D. in Microbial Biotechnology from the University of Putra Malaysia, Malaysia, where she delved into advanced research techniques and microbial interactions. Dr. Alizadeh continued her scholarly journey with a post-doctoral fellowship at the same institution, focusing on cutting-edge microbial biotechnology. Her educational trajectory reflects a strong commitment to understanding microbial systems and advancing biotechnological applications, equipping her with comprehensive knowledge and research capabilities in her field.

Professional Experience

Dr. Fahimeh Alizadeh has an extensive academic and research career, currently serving as an Associate Professor in the Department of Biology at Gachsaran Branch, Islamic Azad University, Iran since 2023. Prior to this role, she was an Assistant Professor at Yasooj Branch, Islamic Azad University from 2000 to 2023, where she also held leadership positions as Head of the Department of Biology and Head of the Department of Paramedical Sciences at different intervals. Her teaching expertise spans across various subjects, including Biology, Medical Biochemistry, Immunology, and Microbiology. Dr. Alizadeh’s research experience is highlighted by her involvement in several significant projects and grants, including studies on microbial interactions, nanoparticles, and antifungal activities. Her contributions to the field are reflected in her numerous journal publications and research grants, underscoring her commitment to advancing scientific knowledge in microbial biotechnology and related disciplines.

Research Interest

Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents.

Research Skills

Dr. Fahimeh Alizadeh demonstrates exceptional research skills in the field of microbiology and microbial biotechnology. Her expertise encompasses a broad range of techniques and methodologies, including the isolation and characterization of transcription factors, the development of nanoparticles for therapeutic applications, and the study of antifungal and antibacterial properties of natural compounds. Dr. Alizadeh excels in molecular profiling and transcriptomic analysis, employing massive parallel sequencing to investigate gene expression during pathogen interactions. Her research frequently involves complex in vitro and in vivo studies, such as evaluating the inhibitory effects of various compounds on pathogenic microorganisms and cancer cell lines. Her ability to synthesize and analyze data from diverse experimental approaches highlights her proficiency in translating fundamental research into practical applications. This comprehensive skill set underscores her significant contributions to advancing knowledge in microbial biotechnology and therapeutic development.

Awards and Recognition

Dr. Fahimeh Alizadeh has garnered notable recognition for her impactful contributions to microbial biotechnology and her extensive research in the field. She has been acknowledged for her groundbreaking work on the molecular mechanisms of antifungal agents and nanoparticles in combating resistant pathogens. Her research projects, such as the study on thymol- and carvacrol-loaded nanoparticles and Candida species, have significantly advanced the understanding of antifungal resistance mechanisms. Dr. Alizadeh’s publications in prominent journals, including Pharmaceutical Sciences and Applied Biochemistry and Biotechnology, highlight her expertise and commitment to advancing medical and environmental microbiology. Her leadership roles as Head of the Department of Biology at Yasooj Branch and her active involvement in international research projects further demonstrate her excellence in academia. These achievements underscore her significant contributions to science and her esteemed position in the research community.

Conclusion

Fahimeh Alizadeh is a highly qualified candidate for the Research for Best Researcher Award, with extensive experience in academia, significant research contributions, and a strong publication record. Her leadership roles and research projects highlight her expertise and commitment to advancing microbial biotechnology.

Publications Top Notes

  • Anti-cancer activity of secreted aspartyl proteinase protein from Candida tropicalis on human cervical cancer HeLa cells
    • Authors: E.P. Kokhdan, P. Khodavandi, M.H. Ataeyan, A. Khodavandi, A. Zaheri
    • Year: 2024
  • Possible Molecular Targeting of Biofilm-Associated Genes by Nano-Ag in Candida albicans
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2024
  • Possibility of intrauterine transmission from mother to fetus/newborn: Systematic review and meta-analysis of diagnostic methods to detect SARS-CoV-2 infection
    • Authors: P. Khodavandi, A. Khodavandi, F. Alizadeh, L. Gholizadeh
    • Year: 2024
    • Citations: 1
  • Hyphae-specific genes: Possible molecular targets for magnetic iron oxide nanoparticles alone and combined with visible light in Candida albicans
    • Authors: P. Khodavandi, A. Hosseini, A. Khodavandi, A. Azizi, M. Gerami
    • Year: 2023
    • Citations: 1
  • Antibacterial and Anti-Biofilm Activities of Microbial Synthesized Silver and Magnetic Iron Oxide Nanoparticles Against Pseudomonas aeruginosa
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 3
  • Biofilm-associated genes as potential molecular targets of nano-Fe3O4 in Candida albicans
    • Authors: M. Baghiat Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 1
  • Synergistic interaction of fluconazole/ sodium bicarbonate on the inhibition of Candida glabrata phospholipase gene
    • Authors: S.M.K. Hosseini, F. Alizadeh, S. Nouripour-Sisakht, A. Khodavandi
    • Year: 2022
  • Resistance profiling of metallo-betalactamase genes in clinical isolates of Enterobacteriaceae: Emergence of multidrug resistance
    • Authors: H. Alizadeh, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2021
    • Citations: 2
  • Antifungal activity of menthol alone and in combination on growth inhibition and biofilm formation of Candida albicans
    • Authors: N. Norouzi, F. Alizadeh, A. Khodavandi, M. Jahangiri
    • Year: 2021
    • Citations: 15
  • Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis
    • Authors: A. Khodavandi, F. Alizadeh, A.F.A. Razis
    • Year: 2021
    • Citations: 28